Pentadecapeptide BPC 157 and the esophagocutaneous fistula healing therapy.

Abstract

Esophagocutaneous fistulas are a failure of the NO-system, due to NO-synthase blockage by the NOS-blocker L-NAME consequently counteracted by l-arginine and gastric pentadecapeptide BPC 157 (l-arginine <BPC 157), precipitating a therapeutic benefit. Previously, there was an established BPC 157-NO-system interaction. BPC 157 GEPPPGKPADDAGLV, MW 1419 (LD1 not achieved), is a safe and stable anti-ulcer peptide, successful in inflammatory bowel disease trials, counteracting esophagitis, sphincter failure, gastrointestinal and skin ulcers, gastrocutaneous or colocutaneous fistulas. We treated rats with established cervical esophagocutaneous fistulas throughout four days (both open skin and esophageal defects, with significant leakage) with BPC 157 (parenterally and perorally) and L-NAME (blocking NO genesis) and l-arginine (NO-substrate) alone or in combination. RT-PCR investigated eNOS, iNOS, COX-2 mRNA levels in the fistulas. We evidenced a closely inter-related process of unhealed skin, esophageal defects, unhealed fistulas (up regulated eNOS, iNOS and COX2 mRNA levels), usually lethal, particularly NO-system related and therapy dependent. Generally, the course of fistula healing was accelerated either to a greater extent (with BPC 157 (in particular, less eNOS gene expression) completely counteracting L-NAME effects, in L-NAME+BPC 157 and L-NAME+l-arginine+BPC 157 groups), or to a lesser extent (with l-arginine). Conversely, the process was aggravated, rapidly and prominently (with L-NAME). In particular, BPC 157 was effective either given per-orally/intraperitoneally, in μg- and ng-regimens. Shortly, defects started to heal, with less fistula leakage and no mortality at day 4. Failure of pyloric and lower esophageal sphincter pressure was restored, with practically no esophagitis.

• Authors: Vedran Cesarec, Tomislav Becejac, Marija Misic, Zeljko Djakovic, Danijela Olujic, Domagoj Drmic, Luka Brcic, Dinko Stancic Rokotov, Sven Seiwerth, Predrag Sikiric
• Journal: European journal of pharmacology (Eur J Pharmacol) Vol. 701 Issue 1-3 Pg. 203-12 (Feb 15 2013) ISSN: 1879-0712 [Electronic] Netherlands
• PMID: 23220707 (Publication Type: Journal Article)
• Copyright: Copyright © 2012 Elsevier B.V. All rights reserved.

Chemical References

• Peptide Fragments
• Proteins
• BPC 157
• Arginine
• NG-Nitroarginine Methyl Ester

Topics

• Animals
• Arginine (pharmacology)
• Cutaneous Fistula (drug therapy, physiopathology)
• Drug Interactions
• Esophageal Diseases (drug therapy, physiopathology)
• Male
• NG-Nitroarginine Methyl Ester (pharmacology)
• Peptide Fragments (pharmacology, therapeutic use)
• Proteins (pharmacology, therapeutic use)
• Rats
• Rats, Wistar
• Wound Healing (drug effects)